AptarGroup's (ATR) Aptar Digital Health division said Thursday that its HeroTracker Sense has received the US Food and Drug Administration's 510k clearance as a Class 2 medical device.
HeroTracker Sense is compatible with multiple asthma and chronic obstructive pulmonary disease medicines, and helps patients oversee their respiratory health through medication and symptom management, Aptar Digital said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.